Table 1.
Demographic details of the study participants (N=220)
| Variables | Values |
|---|---|
| Age (years)$ | 66.6 (13.4) |
| Male : Female | 1 : 1 |
| Body weight (kg)$ | 75.2 (18.1) |
| Predicted liver weight (g) $ | 1148(265) |
| CHA2DS2-VASc score$ | 3.7 (1.5) |
| HASBLED score$ | 2.3 (1.1) |
| SAMe-TT2R2 score$ | 1.4 (0.6) |
| Duration of warfarin (days) $ | 1027 (572.2) |
| Warfarin sensitive index $ | 0.7 (0.4) |
| Log INR variability $ | -0.84 (0.2) |
| Warfarin composite measure score $ | -1.3 (1.2) |
| Number of patients with drugs with potential interaction [n (%)] | 136 (61.8) |
$ - Represented in mean (SD)